<DOC>
	<DOCNO>NCT01678820</DOCNO>
	<brief_summary>The purpose study assess efficacy safety sitagliptin/simvastatin fixed-dose combination ( FDC ) participant T2DM inadequate glycemic control metformin monotherapy . The primary hypothesis study 16 week therapy , mean change baseline hemoglobin A1C ( A1C ) participant treat sitagliptin/simvastatin FDC non-inferior compare sitagliptin alone .</brief_summary>
	<brief_title>A Study Efficacy Safety MK-0431D ( Fixed-dose Combination Sitagliptin Simvastatin ) Treatment Participants With Type 2 Diabetes Mellitus ( T2DM ) With Inadequate Glycemic Control Metformin Monotherapy ( MK-0431D-266 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>T2DM ( 1 ) Male ; ( 2 ) female reproductive potential ; ( 3 ) female reproductive potential agrees remain abstinent use alone conjunction partner 2 method contraception prevent pregnancy study 14 day last dose study drug currently metformin monotherapy daily dose least 1500 mg least 10 week lipidlowering agent least 6 week prior enter study history type 1 diabetes mellitus ( T1DM ) , history ketoacidosis possibly T1DM thiazolidinedione ( TZD ) within previous 16 week treat statin lipidlowering agent ( include overthecounter [ OTC ] supplement ) within previous 6 week currently participate participate another clinical study within past 12 week intend consume &gt; 1.2 liter grapefruit juice daily study likely require treatment least 2 consecutive week repeat course corticosteroid ( inhale , nasal topical corticosteroid permit ) intolerance hypersensitivity sitagliptin , simvastatin , metformin glimepiride weight loss program maintenance phase start weight loss medication undergone bariatric surgery previous 12 month undergone surgical procedure past 4 week plan major surgery study symptomatic hyperglycemia require immediate initiation , adjustment , addition antihyperglycemic therapy history myopathy rhabdomyolysis statin cardiovascular disease , diagnosis congestive heart failure , uncontrolled high blood pressure history active liver disease chronic progressive neuromuscular disorder , human immunodeficiency virus ( HIV ) , hematological disorder , uncontrolled endocrine metabolic disease currently treat hyperthyroidism thyroid hormone therapy stable dose least 6 week history malignancy previous 5 year ( exclude adequately treat basal cell squamous cell skin cancer situ cervical cancer ) pregnant breast feeding , expect conceive donate egg course study , include 14 day last dose study drug user recreational illicit drug recent history drug abuse consume &gt; 2 alcoholic drink per day &gt; 14 alcoholic drink per week , engage binge drinking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>